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It seems that in the past little research has been devoted to the carcinogenic risk produced by progestins. An intensive programme has been developed in our laboratory in recent years to investigate this problem. It has been found that norethynodrel, ethynodiol diacetate and chlormadinone acetate do not accelerate or raise the frequencies of mammary tumours in intact C3H, RIII and (C3H x RIII)F1 females but norethynodrel and ethynodiol diacetate induce such tumours with a high frequency in castrated (C3H x RIII)F1 males. The same compounds have accelerated the appearance of the tumours in castrated (C3H x RIII)F1 females. Chlormadinone acetate does not produce tumours in castrated males and does not accelerate carcinogenesis in the spayed females. Dietary restriction has been shown to reduce the incidence of some tumours in mice (Tannenbaum and Silverstone, Cancer, N. Y., 1957, 1, 306) .
MAMMARY TUMOUR AND
C3H Avy mice have the highest female mammary tumour incidence of any inbred mouse strain (Heston and Vlahakis, J. natn. Cancer Inst., 1968 Inst., , 40, 1161 Hepatomata are common in the male. The strain carries the mammary tumour virus. In spite of this, in our experiments the incidence of these tumours in males and females was abolished completely and the lifespan extended by simple dietary restriction. In the female mammary gland development was inhibited. The lack of a target tissue could explain the absence of mammary tumours in the female but does not explain the reduction of liver tumours in either sex.
These results will be presented as an example of environmental factors influencing the development of tumours even in strongly susceptible hosts. Seven days on a protein deficient diet protects the rat against the lethal effect of a dose of dimethylnitrosamine so that a single dose can be given sufficient to induce kidney tumours in every animal (Swann and McLean, Biochem. J., 1971, 124, 283) . Using this technique the dose response for the induction of kidney tumours is now being determined. This paper reports results obtained up to 80 weeks after injection of carcinogen. Different doses have produced between 10% and 97 % incidence of tumours. Two types of tumours have been found. The predominant tumour is a renal mesenchymal tumour
